Skip to main content
25/04/2016

Vall d'hebron celebrates the Primary Immunodeficiencies Awareness Week

pid_884

25/04/2016

The primary immunodeficiencies affect 1 in every 2,000 babies born in Catalonia. The Vall d'Hebron Campus leads the research and care of these patients in the country.

The Vall d'Hebron Hospital Barcelona Campus celebrates once again the Week of the Primary Immunodeficiencies (PID), organised in Catalonia by the http://bit.ly/1FFaLMt Barcelona PID Foundation with the aim of raising awareness among society about these diseases.The programme of events has started this Monday at the Parc Güell, with the presence of the Minister of health, Toni Comín, and more than a hundred children from the schools CEIP Baldiri and the Escola de Jesuïtes Sant Gervasi-Infant Jesús who have released 250 balloons, one for each of the PID that are known.The PID is a group of diseases of the so-called rare, affecting 1 in every 2,000 babies born alive in Catalonia. The http://bit.ly/1UeWCvi Infectious Pathology and Immunodeficiencies of Paediatrics Unit (UPIIP) at the Vall d'hebron University Hospital leads the attention of paediatric patients, with about 410 diagnosed throughout the country. In total, in Vall d'Hebron have been diagnosed 70% of the PID detected in Catalonia, and treated more than 700 patients.In addition to the attendance, the members of the UPIIP are also on the front line of research of these diseases. Dr. Pere Soler directs the Group of Immunocompromised Paediatric Patients of the Vall d'hebron Research Institute (VHIR), which features a BioBank with more than 100 samples of patients and relatives.The research group has organized for the next 26 April a VHIR http://www.vhir.org/portal1/seminari.asp?contentid=186657&s=activitats&t=SCID:%20from%20100%%20mortality%20to%20100%%20%20survival%20in%2050yrs?" seminar led by Dr. Bobby Gaspar, from Great Ormond Street Hospital in London.

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.